Sensorium Therapeutics

United States
Panora, Iowa, United States

Company profile

Sensorium Therapeutics company profile

Sensorium Therapeutics is a drug discovery platform that develops novel FDA-approved psychoactive medicines. Founded in 2021, the company is based in Boston, Massachusetts.

Business identity

Phone number
562-688-5433
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2021-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$55M
Last funding
Series A / $25M / 2025-08-29
Last equity funding
Series A / $25M
Investors
12
Lead investors
3
Founders
6
Articles
27

Founders and investors

Founders

Alex SimonDick SimonJacob HookerJerrold RosenbaumRichard SimonStephen Haggarty

Lead investors

Route 66 VenturesSante VenturesThe CU Healthcare Innovation Fund

Investors

Hatteras Venture PartnersMission BioCapitalPalo Santo FundRoute 66 VenturesSante Ventures